Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients

Calcineurin inhibitor–associated nephrotoxicity and other adverse events have prompted efforts to minimize/eliminate calcineurin inhibitor use in kidney transplant recipients. METHODS: This open-label, randomized, multinational study evaluated the effect of planned transition from tacrolimus to siro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Direct
Main Authors: Tedesco-Silva, Helio, Peddi, V. Ram, Sánchez-Fructuoso, Ana, Marder, Brad A., Russ, Graeme R., Diekmann, Fritz, Flynn, Alison, Hahn, Carolyn M., Li, Huihua, Tortorici, Michael A., Schulman, Seth L.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2016
Assuntos:
Kidney Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946511/
https://ncbi.nlm.nih.gov/pubmed/27500260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000579
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados